Pharmacy Podcast Network

What happens when your doctor prescribes a medication that does not exist? Not backordered. Not insurance denied. It simply is not made anywhere. In this episode of Rated Rx Podcast, pharmacists break down compounding pharmacy, why it exists, and why some patients would not survive without it. This is one of the most misunderstood areas of healthcare, and it answers a question people search online every day: what happens when standard medications do not work for you? You hear real examples involving pediatric epilepsy, elderly patients with complex medication regimens, feeding tubes, allergies to dyes and fillers, and rare conditions where mass-produced drugs fail. The episode explains how compounding pharmacists legally create customized medications by changing dosage forms, removing allergens, combining medications, and creating formulations that pharmaceutical companies never made. The crew also tackles the biggest misconception around compounding medications, including why compounded drugs are not FDA approved, what regulations actually apply, how USP standards protect patients, and why this work is highly regulated rather than experimental. Sterile compounding, non-sterile compounding, safety checks, pharmacist verification, and real-world problem solving are all explained clearly so you understand how these medications are made safely and legally. This episode helps patients, caregivers, and healthcare professionals understand when compounding is appropriate and why asking about it can change outcomes. For educational and entertainment purposes only. Follow Us At: YouTube https://www.youtube.com/@RatedRxPodcast Instagram https://www.instagram.com/ratedrxpodcast/ Facebook https://www.facebook.com/profile.php?id=61574813907982 TikTok https://www.tiktok.com/@ratedrxpodcast

The Pharmacy 50 Awards are back for the 2025 season, celebrating the people who are pushing the profession forward through leadership, innovation, advocacy, education, and patient care. In Part 1 of this 4-part series, we spotlight an incredible group of pharmacy professionals and industry leaders representing the full spectrum of pharmacy! From independent practice and health systems to digital health, specialty pharmacy, philanthropy, and beyond. This series is designed to recognize the voices shaping the future of pharmacy and to inspire the next wave of leadership across healthcare. 🎙️ Featured Honorees Part One Technology & Digital Health Yalda Olcott, PharmD — Technology & Digital Health Autumn-Kyoko Cushman — Technology & Digital Health Independent Pharmacy Josh Pirestani — Independent Pharmacy Amina Abubakar, PharmD — Independent Pharmacy Shawn Nairn, RPh — Independent Pharmacy Health System / Hospital Pharmacy Ultan McGlone, PharmD — Health System Hospital Pharmacy Alex C. Varkey, PharmD — Health System Hospital Pharmacy Brianna Latta, PharmD — Health System Hospital Pharmacy Academia & Pharmacy Education C. Daniel Mullins, PhD — Academia & Pharmacy Educator Philanthropy | Charitable Pharmacy Jordyn Nordé, PharmD — Philanthropy | Charitable Pharmacy Specialty Pharmacy Laly Havern, PharmD — Specialty Pharmacy Pharmacy Technician Ellaine Sisomphou-Ramos, CPhT — Pharmacy Technician Medical Affairs / Industry Brandon Shank, PharmD — Medical Science Liaison Social Media Influence Laura Dowling, BPharm — Social Media Influencer ⭐ What You’ll Hear in This Episode In this first installment, we highlight how today’s pharmacy leaders are: Advancing innovation and digital transformation Strengthening independent pharmacy impact in local communities Elevating health system pharmacy practice and patient safety Expanding pharmacy’s influence through education, research, and advocacy Supporting access to care through charitable pharmacy and philanthropy Growing specialty pharmacy leadership and patient outcomes Recognizing the essential role of pharmacy technicians Driving clinical education and strategy in medical affairs Using platforms and storytelling to shape pharmacy’s public voice 📌 About the Pharmacy 50 Awards The Pharmacy 50 Awards recognize individuals across pharmacy and healthcare who are creating measurable impact, leading change, and building the future of the profession. The 2025 season showcases innovators, disruptors, and patient-centered leaders who represent pharmacy’s growing role in healthcare delivery.

In this episode of This Week in Pharmacy, we explore how the Pharmacy Podcast Network (PPN) is deepening connections across healthcare by elevating pharmacists’ voices in the conversations that matter most. Inspired by the recent partnership between podcasting giant PodcastOne and the AI-driven analytics platform Listener, we highlight how PPN is using the same type of advanced engagement metrics—combining podcast listener data, social media signals, and network insights—to measure true influence, not just downloads.  With Listener’s powerful data, PPN can now identify where pharmacists are making the greatest impact and uncover new opportunities to expand pharmacist positioning with other providers, industry leaders, and the public. Plus, Todd sits down one-on-one with Kris Rhea of Pharmacy Market Place for an insightful conversation on AI in pharmacy—exploring how artificial intelligence is shaping workflow, clinical decision-making, business operations, and what pharmacists need to know to stay ahead in a rapidly changing healthcare landscape.

In Episode 3 of Pharmacist-Prescribed, hosts Mary Kucek, PMP, Founder and CEO of OvaryIt, and Devin Bustin, MD, Chief Medical Officer of OvaryIt, explore how pharmacies can turn clinical services into sustainable, profitable offerings. The episode breaks down patient acquisition strategies, common billing and reimbursement challenges, staffing considerations, and how pharmacies can integrate clinical care without increasing overhead. Listeners will also learn how technology and policy changes, including the ECAPS Act, play a critical role in positioning pharmacists for long-term success as providers. Learn more about PRISM or request a demo at https://www.getprismrx.com

Cyber threats facing long-term care pharmacies continue to evolve, putting sensitive data, systems, and patient trust at risk. In this episode of FrameworkFocus, host Todd Eury sits down with Scott Beatty, President & CEO of SoftWriters, and Chris Callahan of Echelon Risk + Cyber to explore today’s threat landscape and practical strategies to strengthen cybersecurity maturity. From leadership accountability to real-world defense tactics, discover how pharmacies can improve security hygiene and build resilience without slowing innovation.

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let’s talk about what’s changed and how to better care for our older adults living with diabetes. 2026 Standards of Care in Diabetes:  https://diabetesjournals.org/care/issue/49/Supplement_1 Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES:  https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.  In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.  Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.  In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect with Samuel via: Email: info@valasta.net  Website: ValAsta  FB: ValAsta Youtube: @ValAsta Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

On today’s Executive Dose, host Stephen Beckman is joined by Representative Charity Grimm Krupa, who serves Pennsylvania’s 51st District in the House of Representatives, for a timely and insightful discussion on the evolving healthcare policy landscape in the Commonwealth. Together, they explore recent legislative developments in Pennsylvania that are shaping healthcare delivery, access, and affordability, with a particular focus on how state-level decisions often serve as early indicators for broader national trends. Stephen and Representative Grimm Krupa also examine the ripple effects Pennsylvania healthcare policy can have beyond state borders, highlighting why pharmacists, healthcare leaders, and industry stakeholders across the country should be paying close attention. From regulatory considerations to workforce challenges and patient-centered care initiatives, this episode offers valuable perspective on the intersection of policy, leadership, and healthcare innovation—and what it could mean for the future of healthcare nationwide.

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.  In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.  Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.  In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect with Samuel via: Email: info@valasta.net  Website: ValAsta  FB: ValAsta Youtube: @ValAsta Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Opioidology Part 3: Opioid-Philia vs Opioid-Phobia The often-blurred lines of pain, addiction, and substance use need a deeper dive into the extremes of opioid-philia and opioid-phobia (building upon Opioidology Part 1: Our Opioid Story). Join Mark “Pain Guy” Garofoli and our two guests James Hackworth and Jim Potenziano to take that deeper dive based on their recent collaboration in the Frontiers in Pain Research article “The Burden of Acute Pain in the U.S. in the Wake of the Opioid Crisis”. • Frontiers in Pain Research Article: https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2025.1642035/full  • Article Key Takeaways • Rising Pain Prevalence • Balancing Act—Opioid Utilization vs. Undertreatment • Provider Reluctance to use opioids • Patient Reluctance • Massive Economic Impact • Call for Innovation & Policy Reform • Opioid Story charts: www.painguy.us